Family Preservation Services, Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: Rt 460, Oakwood, VA 24631 Phone: 276-963-3606 |
News Archive
ulrich medical USA, Inc., today announced the U.S. market release of the tezo spine implants for multiple surgical approaches to lumbosacral interbody fusion.
Today, The U.S. Food and Drug Administration approved a novel therapy for patients with metastatic pancreatic adenocarcinoma – the most common form of pancreatic cancer – whose disease has progressed following gemcitabine-based therapy, offering new hope against a disease that will claim the lives of more than 40,000 individuals this year.
Medopad today announced a strategic collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to validate, scale and potentially commercialize the ReVeRe platform as a novel digital biomarker for Alzheimer's disease. This deal was facilitated by Johnson & Johnson Innovation Limited.
Contrary to long-held beliefs, Type I collagen produced by cancer-associated fibroblasts may not promote cancer development but instead plays a protective role in controlling pancreatic cancer progression, reports a new study from researchers at The University of Texas MD Anderson Cancer Center.
› Verified 9 days ago